Where does Onward Medical N.V. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Onward Medical N.V. ranks #11,377 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Onward Medical N.V. hold?

Onward Medical N.V. holds 27 US utility patents granted between 2022 and 2025, spanning 9 technology areas.

What is Onward Medical N.V.'s Innovation Score?

Onward Medical N.V. has an Innovation Score of 49.2 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Onward Medical N.V. focus on?

Onward Medical N.V.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 20 patents, ranking #181 of 1,943 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Onward Medical N.V.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Onward Medical N.V..

What does claim depth mean for Onward Medical N.V.'s patents?

Onward Medical N.V.'s patents average 11.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Onward Medical N.V. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Onward Medical N.V.

USPTO PatentsView assignee record - 27 granted patents across 9 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Onward ranks #11,377 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 9 technology areas.

#11,377
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.2/100): 11.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R11377 · Foreign Corporation #11,377 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 27 grants
UPPER-Q #11,377/49,997
PHOTO-FINISH Okta
CPC-NARROW A61N · 9 areas
INNOV-PAR 49.2/100
CLAIMS-PAR 11.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Okta, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Onward’s 49.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (23%) Velocity 20.0 pts (41%) Breadth 10.6 pts (22%) Claim depth 7.1 pts (14%)

Qualcomm Incorporated · highest

85
Merlin Labs · near

49
Onward Medical · this assignee

49
Oxilio · near

49
Rapsodo PTE · near

49
Tungaloy · near

49
3D Lighting… · lowest

7

What this shows Onward's Innovation Score is 49.2/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Onward?

Each dot is one of Onward’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Onward’s own 11.8 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Onward vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Onward's grants concentrate

Onward Medical N.V. is a focused PatentsView assignee: 9 CPC subclasses with 74.1% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (9 grants) versus a trough of 5 in 2024. By volume, Onward sits between Osiris Therapeutics, Inc. and Patlite Corporation.

Onward's three-year grant acceleration

Onward Medical N.V. shows 23 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Osiris Therapeuti…

27
Okta

27
Oldcastle Buildin…

27
Onepin

27
Optiscan Biomedic…

27
Optumsoft

27
Pason Systems

27
Patlite

27
Onward Medical ◀

27

What this shows Onward holds 27 patents at rank #11,377, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Onward

By rank, the assignees closest to #11,377 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Onward's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Onward, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Onward ranks #181 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Rapsodo PTE. Ltd. 49 Oxilio Ltd 49 Merlin Labs, Inc. 49 Tungaloy Corporation 49

Onward's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Onward Medical N.V. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	9	33.3%
2023	9	33.3%
2024	5	18.5%
2025partial year	4	14.8%

Which technologies does Onward Medical N.V. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 20

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

A61B - DIAGNOSIS; SURGERY; Identification 7

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 2

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 2

H01B - CABLES; CONDUCTORS; INSULATORS; Selection OF Materials FOR Their Conductive, Insulating OR Dielectric Properties 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 1

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Onward Medical N.V.'s patent record in context - here's where to go next.

Onward Medical N.V.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 74.1% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #11,377 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Onward Medical N.V. against Osiris Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.